Fig. 3From: Effectiveness and safety of vedolizumab induction with or without budesonide in patients with moderately to severely active Crohn’s disease in Europe: a retrospective observational studyMean percentage change in APS and LSF from baseline. APS = abdominal pain score; BUD = budesonide; LSF = loose stool frequency; VDZ = vedolizumabBack to article page